The Company is a holding company incorporated in the State of Nevada and not a Chinese operating company. As a holding company with no material operations of our own, we conduct our operations and operate our business in China through our subsidiaries. Holders of our stock hold equity interest in Hongchang International Co., Ltd, a Nevada holding company with business operations in China and therefore, may never hold equity interests directly in our Chinese operating entities. The Company holds equity interests in its PRC subsidiaries through its subsidiaries incorporated in British Virgin Islands and Hong Kong. As we have a direct equity ownership structure, we do not have any agreement or contract between our Company and any of its subsidiaries that is typically seen in a variable interest entity structure.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 12M | 2.9M | 2.7M | - | 96K | - |
| Net Income | 941K | -472K | -379K | -240K | -163K | -548K |
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Free Cash Flow | -5.7M | -11M | -40M | -1.8M | -141K | -22K |
| ROIC | 2.0% | -1.1% | -0.9% | -0.8% | -137.5% | -113.4% |
| Gross Margin | 16.4% | 6.3% | 2.6% | - | 68.6% | - |
| Debt/Equity | 0.19 | 0.18 | 0.24 | -76.61 | -0.70 | -0.10 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | 1.1M | -383K | -470K | -240K | -163K | -279K |
| Operating Margin | 8.9% | -13.4% | -17.5% | - | -168.8% | - |
| ROE | 2.2% | -1.2% | -0.9% | - | - | - |
| Shares Outstanding | 519M | 519M | 519M | 52M | 103M | 103M |
Hongchang International Co., Ltd passes 1 of 9 quality checks, indicating weak fundamentals.
Hongchang International Co., Ltd trades at 54.2x trailing earnings, compared to its 15-year median P/E of 15.0x, suggesting it is currently Expensive relative to its historical range. The company's 5-year average gross margin is 25.8%.
Hongchang International Co., Ltd (HCIL) has a current P/E ratio of 54.2, compared to its historical median P/E of 15.0. The stock is currently considered Expensive based on its historical valuation range.
Hongchang International Co., Ltd (HCIL) has a 5-year average return on invested capital (ROIC) of -50.7%. This is below average and may indicate limited pricing power.
Hongchang International Co., Ltd (HCIL) has a market capitalization of $53M. It is classified as a small-cap stock.
Hongchang International Co., Ltd (HCIL) does not currently pay a regular dividend.
Based on historical P/E analysis, Hongchang International Co., Ltd (HCIL) appears expensive. The current P/E of 54.2 is 261% above its historical median of 15.0.
Hongchang International Co., Ltd (HCIL) operates in the Electromedical & Electrotherapeutic Apparatus industry, within the Healthcare sector.
Hongchang International Co., Ltd (HCIL) reported annual revenue of $3 million in its most recent fiscal year, based on SEC EDGAR filings.
Hongchang International Co., Ltd (HCIL) has a net profit margin of -16.5%. The company is currently unprofitable.
Hongchang International Co., Ltd (HCIL) generated $-11 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
Hongchang International Co., Ltd (HCIL) has a debt-to-equity ratio of 0.18. This indicates a conservatively financed balance sheet.
Hongchang International Co., Ltd (HCIL) has a return on equity (ROE) of -1.2%. A negative ROE may indicate losses or negative equity.
Hongchang International Co., Ltd (HCIL) has a 5-year average gross margin of 25.8%. This lower margin is typical of capital-intensive or commodity businesses.
The Ledger Terminal provides 13 years of financial data for Hongchang International Co., Ltd (HCIL), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Hongchang International Co., Ltd (HCIL) has a book value per share of $0.07, based on its most recent annual SEC filing.
No recent press releases.